Home » Roche’s Rituxan Stops Lymphoma Worsening, Study Says
Roche’s Rituxan Stops Lymphoma Worsening, Study Says
Follicular lymphoma patients receiving Roche and Biogen Idec’s cancer drug Rituxan lived longer without their disease getting worse in a late stage study, the companies said.
Yahoo! Finance UK & Ireland
Yahoo! Finance UK & Ireland
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May